Hanneke M van Santen1,2, Ronald B Geskus3, Steven Raemaekers4, A S Paul van Trotsenburg1, Thomas Vulsma1, Helena J H van der Pal5,6, Hubert N Caron6, Leontien C M Kremer6. 1. Department of Pediatric Endocrinology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. 2. Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands. 3. Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. 4. Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. 5. Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands. 6. Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Abstract
BACKGROUND: Previous studies have reported changes in the body mass index (BMI) with time in childhood cancer survivors (CCSs) during follow-up. The limitations of these studies include that they described only a subgroup of survivors or used questionnaires with self-reported heights and weights. The goal of this study was to examine BMI in a large cohort of long-term CCSs and relate this to the BMI at diagnosis, age, sex, tumor type, treatment, and endocrine defects. METHODS: All patients treated for childhood cancer at the Emma Children's Hospital/Academic Medical Center between 1966 and 1996 who had survived for at least 5 years were eligible for inclusion. For 893 CCSs with a mean follow-up of 14.9 years, the BMI at the late effects outpatient clinic was compared with the BMI for the general Dutch population. RESULTS: For girls, an increased prevalence of obesity was found. Risk factors for developing a high BMI at follow-up were a younger age and a high BMI at diagnosis and treatment with cranial radiotherapy. A significantly increased prevalence of severe underweight was found in all adult subgroups except for females aged 26 to 45 years. An association was found between a low BMI at diagnosis and a low BMI at follow-up. No treatment-related variables could be related to changes in BMI. CONCLUSIONS: The BMI at diagnosis is one of the most important predictors for the BMI at follow-up, and this suggests an important genetic or environmental cause. Adult CCSs are at high risk for developing severe underweight at follow-up. Future studies should focus on the causes and clinical consequences of underweight.
BACKGROUND: Previous studies have reported changes in the body mass index (BMI) with time in childhood cancer survivors (CCSs) during follow-up. The limitations of these studies include that they described only a subgroup of survivors or used questionnaires with self-reported heights and weights. The goal of this study was to examine BMI in a large cohort of long-term CCSs and relate this to the BMI at diagnosis, age, sex, tumor type, treatment, and endocrine defects. METHODS: All patients treated for childhood cancer at the Emma Children's Hospital/Academic Medical Center between 1966 and 1996 who had survived for at least 5 years were eligible for inclusion. For 893 CCSs with a mean follow-up of 14.9 years, the BMI at the late effects outpatient clinic was compared with the BMI for the general Dutch population. RESULTS: For girls, an increased prevalence of obesity was found. Risk factors for developing a high BMI at follow-up were a younger age and a high BMI at diagnosis and treatment with cranial radiotherapy. A significantly increased prevalence of severe underweight was found in all adult subgroups except for females aged 26 to 45 years. An association was found between a low BMI at diagnosis and a low BMI at follow-up. No treatment-related variables could be related to changes in BMI. CONCLUSIONS: The BMI at diagnosis is one of the most important predictors for the BMI at follow-up, and this suggests an important genetic or environmental cause. Adult CCSs are at high risk for developing severe underweight at follow-up. Future studies should focus on the causes and clinical consequences of underweight.
Authors: Wassim Chemaitilly; Zhenghong Li; Matthew J Krasin; Russell J Brooke; Carmen L Wilson; Daniel M Green; James L Klosky; Nicole Barnes; Karen L Clark; Jonathan B Farr; Israel Fernandez-Pineda; Michael W Bishop; Monika Metzger; Ching-Hon Pui; Sue C Kaste; Kirsten K Ness; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Yutaka Yasui; Charles A Sklar Journal: J Clin Endocrinol Metab Date: 2017-07-01 Impact factor: 5.958
Authors: Brianna R Murphy; Margaret P Raber; Karla D Crawford; Leslie Grasse; Lisa Wartenberg; Jimin Wu; Seyedeh S Dibaj; Joya Chandra Journal: Child Obes Date: 2020-03-13 Impact factor: 2.992
Authors: I M A A van Roessel; J van Schaik; A Y N Schouten-van Meeteren; A M Boot; H L Claahsen-van der Grinten; S C Clement; L van Iersel; K S Han; A S P van Trotsenburg; W P Vandertop; L C M Kremer; H M van Santen Journal: Support Care Cancer Date: 2022-04-13 Impact factor: 3.359
Authors: Neha Bansal; M Jacob Adams; Sarju Ganatra; Steven D Colan; Sanjeev Aggarwal; Rudolf Steiner; Shahnawaz Amdani; Emma R Lipshultz; Steven E Lipshultz Journal: Cardiooncology Date: 2019-12-02
Authors: Vincent Pluimakers; Marta Fiocco; Jenneke van Atteveld; Monique Hobbelink; Dorine Bresters; Eline Van Dulmen-den Broeder; Margriet Van der Heiden-van der Loo; Geert O Janssens; Leontien Kremer; Jacqueline Loonen; Marloes Louwerens; Helena Van der Pal; Cécile Ronckers; Hanneke Van Santen; Birgitta Versluys; Andrica De Vries; Marry Van den Heuvel-Eibrink; Sebastian Neggers Journal: JMIR Res Protoc Date: 2021-01-27